Thomas Andrew Rowland sold $357K of ANI Pharmaceuticals (ANIP)

Executed Mar 11, disclosed Mar 13, 2 days later.

Value, as filed

$357K

4,772 sh × $74.91

Executed

Mar 11

the trade date, as filed

Disclosed

Mar 13

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Thomas Andrew Rowland SVP, HEAD - ESTABLISHED BRANDS profile →

Thomas Andrew Rowland (SVP, HEAD - ESTABLISHED BRANDS) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $357K of ANIP (4,772 sh × $74.91, as filed), executed Mar 11.

The name

ANIP

ANI Pharmaceuticals, Inc. ANIP · Healthcare · 50 filings in 24 months ticker →

Healthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Thomas Andrew Rowland in ANIP

ANIPSALE ANI Pharmaceuticals, Inc. $426K
4,975 sh × $85.71
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET